Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (26)

« Back to Publications

Redefining endpoints in heart failure clinical trials: the emerging role of wearable technologies in contemporary trial design.

Alawoad Z. et al, (2025), Heart Fail Rev, 31

Targeting Cardiac Metabolism in Heart Failure with PPARα Agonists: A Review of Preclinical and Clinical Evidence.

Handford C. et al, (2025), Biomedicines, 13

The Emerging Role of Computed Tomography Coronary Angiography in the Left Main Stem Percutaneous Coronary Intervention.

Shabbir A. et al, (2025), Rev Cardiovasc Med, 26

Editorial: Advances in multi-modality imaging for precision medicine in cardiomyopathies.

Wamil M. and Androulakis E., (2025), Front Cardiovasc Med, 12

Blood pressure management in type 2 diabetes: a review of recent evidence.

Wamil M. et al, (2024), Heart, 110, 1254 - 1260

Multi-modality cardiac imaging confirms quadricuspid aortic valve and excludes papillary fibroelastoma.

Wamil M. and Goncalves M., (2024), Eur Heart J Imaging Methods Pract, 2

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.

Nazarzadeh M. et al, (2022), Lancet Diabetes Endocrinol, 10, 645 - 654

Blood pressure meta-analysis highlights an implementation gap - Authors' reply.

Rahimi K. et al, (2022), Lancet, 399

Multi-modality cardiac imaging in the management of diabetic heart disease.

Wamil M. et al, (2022), Front Cardiovasc Med, 9

Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.

Nazarzadeh M. et al, (2021), Lancet, 398, 1803 - 1810

Blood pressure lowering and risk of new-onset type 2 diabetes: an individual level meta-analysis of 145,000 randomized participants

CANOY D. et al, (2021), The Lancet

Increased Risk of Incident Heart Failure and Death Is Associated With Insulin Resistance in People With Newly Diagnosed Type 2 Diabetes: UKPDS 89.

Wamil M. et al, (2021), Diabetes Care, 44, 1877 - 1884

Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study.

Dennis A. et al, (2021), BMJ Open, 11

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: Insights from the Acarbose Cardiovascular Evaluation (ACE) trial.

Wamil M. et al, (2020), Diabetes Res Clin Pract, 170

Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS.

De Ferrari GM. et al, (2020), Am Heart J, 220, 82 - 88

Load More